A61K 38/195
Chemokines
Official title: {Chemokines, e.g. RANTES}
A61K38/195 (Chemokines) appears on 308 US grants and 650 published applications in this corpus.
Search patents in A61K- Granted patents
- 308
- Published applications
- 650
- Assignees
- 389
- Inventors
- 1,202
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 20 |
| 2003 | 5 | 19 |
| 2004 | 4 | 16 |
| 2005 | 3 | 21 |
| 2006 | 2 | 24 |
| 2007 | 8 | 21 |
| 2008 | 4 | 13 |
| 2009 | 5 | 17 |
| 2010 | 7 | 24 |
| 2011 | 7 | 13 |
| 2012 | 8 | 16 |
| 2013 | 12 | 17 |
| 2014 | 12 | 29 |
| 2015 | 9 | 20 |
| 2016 | 12 | 34 |
| 2017 | 14 | 30 |
| 2018 | 24 | 39 |
| 2019 | 19 | 41 |
| 2020 | 21 | 36 |
| 2021 | 22 | 37 |
| 2022 | 28 | 43 |
| 2023 | 14 | 31 |
| 2024 | 16 | 38 |
| 2025 | 22 | 35 |
| 2026 | 11 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combination immunotherapy15 Sep 2026US 12,735,466 B2The Regents of the University of California
- Net stabilization as a therapy for sepsis8 Sep 2026US 12,728,153 B2The Children’s Hospital of Philadelphia
- Methods and compositions for treating cancer with von Willebrand factor peptide linked to immunotherapeutic antibodies11 Aug 2026US 12,706,227 B2The University of Chicago
- Compositions and methods comprising viral vector systems for multiplexed activation of endogenous genes as immunotherapy and viral-based immune-gene therapy4 Aug 2026US 12,697,398 B2Yale University
- Compositions and methods for inhibiting the biological activity of soluble biomolecules21 Jul 2026US 12,685,758 B2NaNotics, LLC
- Compositions and Methods for Treatment of Muscle Disease with Chronic Inflammation27 Aug 2026US 2026/0248887 A1New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special
- The use of cannabidiol (cbd) as a combination treatment for glioblastoma20 Aug 2026US 2026/0240875 A1University of South Florida
- Engineered nucleic acids and methods of use thereof6 Aug 2026US 2026/0224664 A1Moderna TX, Inc.
- Her receptor derived peptides and methods of use thereof16 Jul 2026US 2026/0200982 A1Ramot at Tel-Aviv University Ltd.
- Coacervate formulations of cxcr-activating peptides for controlled release in ophthalmic and topical treatments16 Jul 2026US 2026/0201006 A1Cornell University
Most cited
By later US patents
- Engineered nucleic acids and methods of use thereof372US 8,822,663 B2Moderna Therapeutics, Inc. · 2014
- Solid compositions containing glipizide and polyethylene oxide105US 6,348,469 B1Pharma Pass LLC · 2002
- Engineered nucleic acids and methods of use thereof91US 9,181,319 B2Moderna Therapeutics, Inc. · 2015
- Methods to mobilize progenitor/stem cells62US 7,169,750 B2AnorMED, Inc. · 2007
- T-cell redirecting bispecific antibodies for treatment of disease39US 9,315,567 B2IBC Pharmaceuticals, Inc. · 2016